$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2023 Q3 Form 10-Q Financial Statement

#000162828023027771 Filed on August 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $16.10M $15.83M
YoY Change -49.02% -51.18%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $26.78M $26.69M
YoY Change -15.31% -18.47%
% of Gross Profit
Research & Development $93.79M $94.76M
YoY Change 15.61% 31.28%
% of Gross Profit
Depreciation & Amortization $3.893M $2.900M
YoY Change 46.35% 31.82%
% of Gross Profit
Operating Expenses $124.4M $118.5M
YoY Change 7.82% 12.54%
Operating Profit -$102.7M
YoY Change 40.86%
Interest Expense -$1.377M $5.158M
YoY Change -186.99% 315.97%
% of Operating Profit
Other Income/Expense, Net $717.0K -$680.0K
YoY Change 696.67% -178.79%
Pretax Income -$109.0M -$103.4M
YoY Change 32.66% 43.5%
Income Tax $2.025M $742.0K
% Of Pretax Income
Net Earnings -$109.7M -$102.9M
YoY Change 28.26% 42.89%
Net Earnings / Revenue -681.36% -650.53%
Basic Earnings Per Share -$0.96
Diluted Earnings Per Share -$1.02 -$0.96
COMMON SHARES
Basic Shares Outstanding 107.2M shares 106.9M shares
Diluted Shares Outstanding 107.0M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $403.6M $451.7M
YoY Change 7.23% 8.45%
Cash & Equivalents $110.9M $105.3M
Short-Term Investments $292.7M $346.4M
Other Short-Term Assets $7.082M $7.162M
YoY Change -64.95% -19.46%
Inventory
Prepaid Expenses $8.813M $10.05M
Receivables $0.00 $1.247M
Other Receivables $0.00 $0.00
Total Short-Term Assets $419.5M $470.2M
YoY Change 3.51% 8.74%
LONG-TERM ASSETS
Property, Plant & Equipment $290.3M $231.4M
YoY Change 163.16% 221.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $42.76M
YoY Change -100.0% -74.23%
Other Assets $210.0K $210.0K
YoY Change -3.67% -23.64%
Total Long-Term Assets $346.0M $325.7M
YoY Change 20.72% 1.97%
TOTAL ASSETS
Total Short-Term Assets $419.5M $470.2M
Total Long-Term Assets $346.0M $325.7M
Total Assets $765.6M $795.9M
YoY Change 10.64% 5.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $35.87M $7.874M
YoY Change 1150.56% 33.59%
Accrued Expenses $39.76M $38.19M
YoY Change -15.14% 17.51%
Deferred Revenue $866.0K $16.91M
YoY Change -98.83% -79.94%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $105.5M $70.23M
YoY Change -24.05% -45.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $372.9M $669.0K
YoY Change 176.76% -99.55%
Total Long-Term Liabilities $372.9M $343.6M
YoY Change 176.76% 130.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $105.5M $70.23M
Total Long-Term Liabilities $372.9M $343.6M
Total Liabilities $478.4M $413.9M
YoY Change 74.85% 49.09%
SHAREHOLDERS EQUITY
Retained Earnings -$1.026B -$916.4M
YoY Change 25.01% 24.63%
Common Stock $1.301B $1.282B
YoY Change 6.66% 7.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $271.3M $364.8M
YoY Change
Total Liabilities & Shareholders Equity $765.6M $795.9M
YoY Change 10.64% 5.86%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$109.7M -$102.9M
YoY Change 28.26% 42.89%
Depreciation, Depletion And Amortization $3.893M $2.900M
YoY Change 46.35% 31.82%
Cash From Operating Activities -$25.29M -$21.45M
YoY Change -63.17% -68.85%
INVESTING ACTIVITIES
Capital Expenditures $63.94M $46.61M
YoY Change -295.46% -588.73%
Acquisitions
YoY Change
Other Investing Activities $94.38M $36.70M
YoY Change 36.48% -48.17%
Cash From Investing Activities $30.55M -$9.905M
YoY Change -16.19% -116.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 153.0K 1.805M
YoY Change -82.11% -97.02%
NET CHANGE
Cash From Operating Activities -25.29M -21.45M
Cash From Investing Activities 30.55M -9.905M
Cash From Financing Activities 153.0K 1.805M
Net Change In Cash 5.408M -29.55M
YoY Change -117.24% -155.71%
FREE CASH FLOW
Cash From Operating Activities -$25.29M -$21.45M
Capital Expenditures $63.94M $46.61M
Free Cash Flow -$89.23M -$68.05M
YoY Change 148.16% 14.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1247000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1410000 usd
CY2023Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
346369000 usd
CY2022Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
268391000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10053000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7289000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
7162000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
20204000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
470165000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
405299000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
231369000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
110297000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10687000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11962000 usd
CY2023Q2 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
42758000 usd
CY2022Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
105872000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40667000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58291000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
210000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
218000 usd
CY2023Q2 us-gaap Assets
Assets
795856000 usd
CY2022Q3 us-gaap Assets
Assets
691939000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7874000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2868000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38191000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46856000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4434000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12251000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2823000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2776000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16905000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
74099000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
70227000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
138850000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
79911000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
78800000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
55950000 usd
CY2023Q2 arwr Royalties Liability Noncurrent
RoyaltiesLiabilityNoncurrent
263064000 usd
CY2022Q3 arwr Royalties Liability Noncurrent
RoyaltiesLiabilityNoncurrent
0 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
669000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
343644000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
134750000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
290000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107102000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107102000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105960000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105960000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
199000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
198000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1281393000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1219213000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-411000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-136000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-916351000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-820755000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
364830000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
398520000 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
17155000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
19819000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
381985000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
418339000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
795856000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
691939000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15825000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32412000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
224638000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
211656000 usd
CY2023Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
94757000 usd
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
72180000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
253333000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
213930000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23771000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33141000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
67977000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
92403000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
118528000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
105321000 usd
us-gaap Operating Expenses
OperatingExpenses
321310000 usd
us-gaap Operating Expenses
OperatingExpenses
306333000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-102703000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-72909000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-96672000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-94677000 usd
CY2023Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
4172000 usd
CY2022Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1240000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
11414000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3450000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
5158000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
13064000 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
306000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-377000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
821000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
675000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-680000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
863000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-829000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4125000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-103383000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-72046000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-97501000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-90552000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
742000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
759000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-104125000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-72046000 usd
us-gaap Profit Loss
ProfitLoss
-98260000 usd
us-gaap Profit Loss
ProfitLoss
-90552000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1179000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2664000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-102946000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-72046000 usd
us-gaap Net Income Loss
NetIncomeLoss
-95596000 usd
us-gaap Net Income Loss
NetIncomeLoss
-90552000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107004000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105753000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106597000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105273000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107004000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105753000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106597000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105273000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-275000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-71000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-98535000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-90623000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
418339000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19390000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
576000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-122000 usd
CY2022Q4 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
486000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-41325000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
396372000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20612000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
520000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-74000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
999000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
48675000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
465106000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19947000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1136000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-79000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
1179000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-102946000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
381985000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
408822000 usd
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24504000 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-39000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-62872000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
372560000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33802000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1537000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
44366000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
452266000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33391000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
599000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33000 usd
CY2023Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
60000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-72046000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
59949000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8634000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7761000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
1030000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-2013000 usd
arwr Non Cash Interest Expense Liability Related To Sale Of Future Royalties
NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties
13064000 usd
arwr Non Cash Interest Expense Liability Related To Sale Of Future Royalties
NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties
0 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-5755000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-164000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10016000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-27913000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8867000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5001000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3563000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-32082000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1713000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-113144000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-87100000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
1158000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
3733000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-128633000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-67394000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
112830000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20066000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
233984000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
223391000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
220150000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
201595000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-126664000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41862000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2232000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4331000 usd
arwr Proceeds From Sale Of Future Royalties
ProceedsFromSaleOfFutureRoyalties
250000000 usd
arwr Proceeds From Sale Of Future Royalties
ProceedsFromSaleOfFutureRoyalties
0 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
60000000 usd
arwr Proceeds From Tenant Improvement Allowance
ProceedsFromTenantImprovementAllowance
669000 usd
arwr Proceeds From Tenant Improvement Allowance
ProceedsFromTenantImprovementAllowance
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
252901000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64331000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2396000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-44925000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-275000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-70000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
108005000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
184434000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
105334000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
139439000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105300000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7300000 usd
CY2023Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
346400000 usd
CY2023Q2 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
42800000 usd
arwr Increase Decrease In Cash And Investments
IncreaseDecreaseInCashAndInvestments
12200000 usd
CY2023Q2 arwr Development Regulatory And Sales Milestones Payments
DevelopmentRegulatoryAndSalesMilestonesPayments
3400000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15825000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32412000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
224638000 usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
1539000 usd
CY2022Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
6174000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16905000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
130049000 usd
CY2022Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
105872000 usd
CY2023Q2 arwr Computers Software Office Equipment And Furniture Gross
ComputersSoftwareOfficeEquipmentAndFurnitureGross
2198000 usd
CY2022Q3 arwr Computers Software Office Equipment And Furniture Gross
ComputersSoftwareOfficeEquipmentAndFurnitureGross
2182000 usd
CY2023Q2 us-gaap Land
Land
2996000 usd
CY2022Q3 us-gaap Land
Land
2996000 usd
CY2023Q2 arwr Research Equipment Gross
ResearchEquipmentGross
50472000 usd
CY2022Q3 arwr Research Equipment Gross
ResearchEquipmentGross
38283000 usd
CY2023Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
96344000 usd
CY2022Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
42017000 usd
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
118279000 usd
CY2022Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
56373000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
270289000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
141851000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38920000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31554000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
231369000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
110297000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2900000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2200000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7400000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6500000 usd
CY2023Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
346369000 usd
CY2023Q2 arwr Debt Securities Held To Maturity Accumulated Unrecognized Gain Current
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedGainCurrent
0 usd
CY2023Q2 arwr Debt Securities Held To Maturity Accumulated Unrecognized Loss Current
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedLossCurrent
4204000 usd
CY2023Q2 us-gaap Debt Securities Held To Maturity Fair Value Current
DebtSecuritiesHeldToMaturityFairValueCurrent
342165000 usd
CY2023Q2 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
42758000 usd
CY2023Q2 arwr Debt Securities Held To Maturity Accumulated Unrecognized Gain Noncurrent
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedGainNoncurrent
0 usd
CY2023Q2 arwr Debt Securities Held To Maturity Accumulated Unrecognized Loss Noncurrent
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedLossNoncurrent
294000 usd
CY2023Q2 us-gaap Debt Securities Held To Maturity Fair Value Noncurrent
DebtSecuritiesHeldToMaturityFairValueNoncurrent
42464000 usd
CY2022Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
268391000 usd
CY2022Q3 arwr Debt Securities Held To Maturity Accumulated Unrecognized Gain Current
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedGainCurrent
0 usd
CY2022Q3 arwr Debt Securities Held To Maturity Accumulated Unrecognized Loss Current
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedLossCurrent
3661000 usd
CY2022Q3 us-gaap Debt Securities Held To Maturity Fair Value Current
DebtSecuritiesHeldToMaturityFairValueCurrent
264730000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 arwr Debt Securities Held To Maturity Accumulated Unrecognized Gain Noncurrent
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedGainNoncurrent
0 usd
CY2022Q3 arwr Debt Securities Held To Maturity Accumulated Unrecognized Loss Noncurrent
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedLossNoncurrent
5569000 usd
CY2022Q3 us-gaap Debt Securities Held To Maturity Fair Value Noncurrent
DebtSecuritiesHeldToMaturityFairValueNoncurrent
100303000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
425000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1700000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700000 usd
CY2023Q2 arwr Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
3462000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10687000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
290000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107102000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107102000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105960000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105960000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
290000000 shares
CY2023Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2021Q4 arwr Tax Increment Financing Award
TaxIncrementFinancingAward
16000000 usd
CY2021Q4 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
2500000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40667000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58291000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2823000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2776000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
79911000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
78800000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
4089000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
3601000 usd
us-gaap Lease Cost
LeaseCost
9904000 usd
us-gaap Lease Cost
LeaseCost
6564000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
600000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
200000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1200000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
700000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1143000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8094000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11800000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12148000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11320000 usd
CY2023Q2 arwr Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
102812000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
147317000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
64583000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
82734000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
4430000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3398000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y4M24D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.080
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
6186644 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2365798 shares
CY2023Q2 arwr Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstanding
6687864 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19947000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33390000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59949000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
91697000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2721384 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
32151 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
33.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
43936 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
62.31
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
343801 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.48
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2365798 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.20
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
43813599 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2188690 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.28
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y2M12D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
43480339 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0369
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.864
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-102946000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-72046000 usd
us-gaap Net Income Loss
NetIncomeLoss
-95596000 usd
us-gaap Net Income Loss
NetIncomeLoss
-90552000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107004000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105753000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106597000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105273000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107004000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105753000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106597000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105273000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3467000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4024000 shares
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-23-027771-index-headers.html Edgar Link pending
0001628280-23-027771-index.html Edgar Link pending
0001628280-23-027771.txt Edgar Link pending
0001628280-23-027771-xbrl.zip Edgar Link pending
arwr-20230630.htm Edgar Link pending
arwr-20230630.xsd Edgar Link pending
arwr-20230630xexx311.htm Edgar Link pending
arwr-20230630xexx312.htm Edgar Link pending
arwr-20230630xexx321.htm Edgar Link pending
arwr-20230630xexx322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
arwr-20230630_cal.xml Edgar Link unprocessable
arwr-20230630_def.xml Edgar Link unprocessable
arwr-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
arwr-20230630_pre.xml Edgar Link unprocessable
arwr-20230630_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending